Kevan Herold

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Sanofi
    Topic: 
    teplizumab
    Date added: 
    10/25/2023
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/14/2023
  • Attribution: 
    Spouse or Partner
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    Sanofi
    Topic: 
    teplizumab
    Date added: 
    10/25/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    09/18/2023
    Date reviewed: 
    11/14/2023
Return to 17th Biennial Meeting of the Diabetes in Pregnancy Study Group